Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CRN’s board changes

This article was originally published in The Tan Sheet

Executive Summary

The Council for Responsible Nutrition has elected Marjorie Fine, executive VP and general council for Shaklee, as chair, CRN announces Dec. 7. Fine will succeed Kemin Health Senior VP Chuck Brice as chair of the association and will hold the office from January 2007 through December 2008. "During my two-year term, I intend to work closely with [CRN President] Steve [Mister] and cooperatively with our member companies, on an agenda that focuses on industry responsibility and further acceptance of our products as part of mainstream healthcare," Fine says in a statement. Brice will remain on CRN's board of directors and executive committee. Other newly elected officers to the board include Chair-elect Mark LeDoux, of Natural Alternative International; Treasurer David Christensen, of Bayer; and Secretary Joe LaPlaca, of DSM Nutritional Products...

You may also be interested in...

New China COVID Vaccine Arriving But COVAX Pledge May Need A Booster

China’s first domestically-developed recombinant protein vaccine for COVID-19 moves forward in late-stage trials in two countries.

QUOTED. 9 March 2021. Matthew Trerotola.

Splitting Colfax into separate fabrication technology and specialty medical technology businesses will help both sides of the business grow, CEO Matthew Trerotola said recently.

Catchup Capsule: Key APAC Insights You Need To Read

Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This selection of recent insights from our experienced on-the-ground team will help.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts